NDC 0074-1044-01
EMRELIS 20 mg/mL
Telisotuzumab Vedotin · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
EMRELIS is a injection, powder, lyophilized, for solution containing telisotuzumab vedotin at a strength of 20 mg/mL. Manufactured by AbbVie Inc..
Key Facts
- Brand Name
- EMRELIS
- Generic Name
- Telisotuzumab Vedotin
- NDC Code (Package)
0074-1044-01- NDC Code (Product)
0074-1044- Manufacturer
- AbbVie Inc.
- Strength
- 20 mg/mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761384
- Marketing Start
- 05/14/2025
Recall History
No Recall HistoryView Full Drug Page
EMRELIS — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.